Nexstim Plc · OMXHEX:NXTMH
Nexstim — Redeye Life Science Day 2022
14 slides from Nexstim's conference presentation, Nov 24, 2022
Slide 1: Nexstim as an Investment - Personalized Brain Diagnostics and Therapy
Nexstim as an Investment - Personalized Brain Diagnostics and Therapy Mikko Karvinen| CEO| Nexstim Plc Redeye Life Science Day, November 2022 Nexstim Oyj
Slide 2: Important Information
Important Information This document and the information contained herein are being presented by Nexstim Oyj other than the date of this presentation. Nothing contained herein is, or should be relied upon (“Nexstim” or the “Company”). In connection with any presentation or review of this document, as
Slide 3: Content of the Presentation
Content of the Presentation 1. Nexstim story 2. Megatrends that support our growth 3. Business and products 4. Why invest in Nexstim? 5. Business update and financial key figures 6. Strategic objectives 7. Technology development and future research Nexstim Oyj Nexstim Plc Public Presentation 3
Slide 4: Nexstim Story
Nexstim Story Nexstim is a Finnish, globally operating growth-oriented medical technology company. MISSION VISION VALUES • We enable personalized and • With our technological know-how • Science and clinical evidence effective therapies and and superior services, • Financial success diagnostics for c
Slide 5: Megatrends that Support our Growth
Megatrends that Support our Growth Nexstim’s unique proprietary neuronavigated TMS-technology for both diagnostic and therapy applications. 1 2 3 Technological Healthcare cost Aging population development in pressures healthcare • Population aging and a • Technological • The need for more significan
Slide 6: Our Business and Products
Our Business and Products Commercial Business System Application Europe United States Status NBS Diagnostics (Navigated Over 210 Pre-surgical FDA CE marked Business Brain systems sold mapping approved Stimulation) FDA approved NBT® Over 60 Depression CE marked with existing Therapy (Navigated system
Slide 7: Why Invest in Nexstim? 1/2
Why Invest in Nexstim? 1/2 1 2 3 4 NEXSTIM IS A MEDICAL COMMERCIAL PRODUCT UNIQUE SCALABLE MEGATRENDS SUPPORT TECHNOLOGY GROWTH COMPANY PORTFOLIO IN A STRONGLY TECHNOLOGY PLATFORM OUR GROWTH IN A DEFENSIVE INDUSTRY REGULATED INDUSTRY Nexstim is a Finnish, globally Our neuronavigated TMS We operate i
Slide 8: Why Invest in Nexstim? 2/2
Why Invest in Nexstim? 2/2 5 6 7 FOCUS IN THE LONG-TERM RECURRING REVENUE STRONG ORGANIZATION AND SHAREHOLDER VALUE SUPPORTS OUR GROWTH COMMITTED TEAM OF EXPERTS Nexstim is an investment Our business is built on a solid base Our Board and management team opportunity due to increased and our systems
Slide 9: Business and Financial Summary H1 2022
Nexstim Business and Financial Summary H1 2022 • Nexstim’s historically best half year measured by net sales and • Diagnostics Business (NBS) net sales grew by 19.3% in H1 2022 operating profit to EUR 2.1M (H1 2021: EUR 1.8M) and the Therapy Business (NBT®) net sales grew by 290.4% in H1 2022 amount
Slide 10: H1 2022 Key Financials
H1 2022 Key Financials Key Financials of the Group Total net sales 6.8M€ +130% 1–6/2022 1–6/2021 1–12/2021 • NBS net sales 2.1M€ +19% EUR in thousands Change-% 6 months 6 months 12 months • NBT net sales 4.7M€ +290% • System sales 1.8M€ +11% Net Sales 6,793.0 2,958.6 129.6 6,397.5 • Recurring revenu
Slide 11: Key Strategic Objectives 2022
Nexstim Key Strategic Objectives 2022 1 2 Continued profitable net Expansion of Nexstim’s sales growth, leading into network of exclusive our first operating profit- neuroscience center making financial year, partner clinics, especially while also minimizing in the United States future capital needs
Slide 12: Nexstim Technology
Nexstim Technology Further Developing our Integrated Platform for Future Brain Diagnostics and Therapy TARGETING ACTIVATION MEASUREMENT • Stereotactic • TMS • EMG • E-Field navigation • Multi-locus • EEG • Brain network connectivity • Combined with • ECG • DTI Peripheral Nerve • HRV Stimulation • Co
Slide 13: Research – Preparing for Possible Future Indications
Research – Preparing for Possible Future Indications Developing the future clinical usage possibilities of Nexstim’s unique proprietary neuronavigated TMS-technology for both diagnostic and therapy applications. • Consciousness measurement 1 Diagnostics • Neuroplasticity measurement • Chronic Neurop
Slide 14: Thank you!
Thank you! Follow us on social media: Nexstim Oyj Nexstim Plc Public Presentation 14